How to invest in life settlements: a complete 2026 guide.

Let me be honest with you up front: most guides on this topic read like marketing brochures. They tell you the asset class has "attractive uncorrelated returns" and leave it there. That's not useful when you're trying to decide whether to put real money into a policy. So I wrote this differently. I'll show you the actual math on a real-world policy, the five things I personally check before recommending any transaction, and exactly where this can go wrong if you're not careful.

How a life settlement investment actually works

When someone asks me to explain this, I usually start with the simplest version: a senior citizen sells their life insurance policy to an investor instead of letting it lapse. The investor takes over the premiums and eventually receives the death benefit. That's it. Everything else is just mechanics.

The transaction is fully legal in 43 U.S. states, and the legal foundation goes back over a century. The U.S. Supreme Court ruled in Grigsby v. Russell, 222 U.S. 149 (1911) that a life insurance policy is personal property — just like a house or a car — and can be freely sold. The federal SEC Investor Bulletin on Life Settlements walks through the basics if you want the official government explanation.

In practice, there are four parties involved in every transaction: the policyholder selling the policy, the licensed provider or marketplace facilitating the deal, the investor buying it, and the insurance carrier who eventually writes the check. Understanding what each one does is the difference between feeling confident in a transaction and feeling like you're guessing.

Here's what actually happens, start to finish:

1. 1

   Policy origination

   A senior — typically 75 or older with a policy of $100,000 or more — decides they no longer need or can afford their life insurance. Most of the time, the kids are grown, the spouse is gone, or the annual premiums have just become too expensive on a retirement income. Instead of letting the policy lapse (which means getting nothing) or surrendering it back to the insurer (which usually means getting pennies on the dollar), they sell it through a licensed life settlement provider. I've seen policies where the difference between the surrender value and what a seller actually received was six figures.

2. 2

   Life expectancy underwriting

   This is where the real work happens. Independent actuarial firms — usually 21st Services or Fasano Associates, the two I trust most — review the insured's medical records and produce a life expectancy estimate, or "LE." This number drives everything. It determines how long you'll hold the policy, how much you'll pay in premiums, and ultimately what your return looks like. Honestly, if an LE report comes from a firm I've never heard of, that's where I stop looking at the deal.

3. 3

   Policy pricing and acquisition

   The investor pays more than what the insurance company would give the policyholder to surrender, but less than the death benefit. The difference between what you pay and the death benefit — minus all the premiums you'll cover during the holding period — is your gross return. Pricing is driven by four things: the LE estimate, the carrier's credit rating, the policy type, and the face value. Get any of those wrong and the whole economics shift.

4. 4

   Premium servicing during the holding period

   Here's the part that ruins more self-directed deals than any other: missed premium payments. Once you own the policy, you have to keep paying premiums to keep it in force. Miss one for too long and the whole thing lapses — and all your capital goes with it. This is why I always recommend working with a platform that runs a premium reserve structure. You don't want to be in a position where a single late payment wipes out a seven-figure investment.

5. 5

   Death benefit collection

   When the insured eventually passes away, the insurance carrier pays the full death benefit directly to whoever owns the policy at that point — you, or whatever entity you set up to hold it. This is why the carrier's rating matters so much. An A-rated carrier is going to pay, full stop. Anything below investment grade, and you're introducing a risk that's entirely avoidable. In the HYV network, we only work with A-rated carriers. Not because it's a marketing line — because it's the only thing that makes sense.

The mechanics are the same whether you go the direct-ownership route (buying individual policies) or through a pooled fund. Where they actually differ — and it matters a lot — is in transparency, control, fees, and who captures the upside if a policy matures early. I'll walk through that in Section 4. For context on the size of this market, the European Life Settlement Association factsheet estimates the addressable market at roughly $200 billion in lapsable policy supply each year — and the secondary market has historically transacted only about 2% of that. There's a lot of room left.

The math behind your return: a real example

Let me show you a specific policy so the returns stop feeling abstract. This isn't a hypothetical I made up to sell you something — it's the structure of a typical deal I've walked investors through many times over the years. I'm going to use round numbers to keep it simple, but the mechanics are real.

Picture a $500,000 universal life policy on a 76-year-old man. His wife passed away a few years ago, the kids are financially independent, and the $12,000 annual premium is eating into his retirement. The insurance company has offered him around $42,000 to surrender the policy. An investor, going through a proper licensed provider, would pay him significantly more — let's say $185,000.

Here's how the numbers break down:

Now here's the part that nobody explains clearly, and it's the most important thing I'm going to tell you in this entire guide: longevity risk is real, and it cuts both ways. If the insured lives two years longer than the projection — nine years instead of seven — you pay an extra $24,000 in premiums. Your IRR drops from about 10.2% to around 7.8%. Still a positive return. Still uncorrelated to the stock market. But it's not the 10% you modeled.

This is exactly why the SEC's official Investor Bulletin on Life Settlements calls out longevity risk as the primary investor risk in this asset class. The bulletin puts it plainly: "the competence of a life expectancy underwriter and the accuracy of the life expectancy estimate are critical to the return on a life settlement." I agree with that statement completely — it's why the LE provider is non-negotiable for me.

Now the flip side: if the insured passes two years earlier than projected — at year five instead of seven — your premiums drop to $60,000, your capital deployed is $245,000, and your IRR jumps to about 13.6%. I'm not going to pretend that's pleasant to talk about. The reality is that you're looking at a mortality-linked asset, and that comes with a discomfort that other investments don't have. I've had investors walk away from the asset class entirely because of this, and I understand why. It's a personal decision. But I'd rather tell you honestly what you're buying than dress it up as something it isn't.

5-point due diligence framework before you invest

If you take only one thing away from this guide, make it this checklist. Over the years I've seen smart investors lose money on life settlements not because the asset class is broken, but because they skipped one of these five checkpoints. Every policy you look at should clear all five — no exceptions.

I'll tell you exactly what to ask, and more importantly, what a "no" answer actually means.

1. Life Expectancy Provider Quality

The LE report is the foundation of everything. If the projection is off, every other number in the deal is off with it. The two firms I've seen produce consistently reliable work are 21st Services and Fasano Associates — both are the recognized standard in the industry. They have proprietary mortality databases, peer-reviewed models, and decades of track record. If the LE on a policy I'm looking at comes from a firm I don't recognize, that's my first red flag. Sometimes that's legitimate and they're just smaller. But usually it's not. Ask: Who produced the LE? When was it issued? Has it been refreshed in the past 12 months? Stale LE reports are a bigger problem than most investors realize.

2. Insurance Carrier Rating

The carrier is the one who's eventually going to write you a check. So their financial health matters enormously. I only work with policies issued by carriers rated A or above by AM Best. I know that sounds strict, and yes, it does mean I pass on some policies that other investors would take. But here's my logic: a BBB-rated carrier probably pays too. Until one day they don't, or they get into a dispute, or they're acquired and the new parent decides to contest claims. That's a low-probability event. It's also a totally avoidable one. Ask: What's the current AM Best rating? Has it changed in the past 24 months? Ratings drift. Check it fresh, don't trust what's in the original paperwork.

3. Premium Reserve Structure

This is the operational thing that sinks more deals than any other, and it's the part most guides skip entirely. Once you own the policy, someone has to keep paying premiums — which means someone has to have the cash set aside to do it. A properly structured investment has a funded premium reserve: a separate pool of capital earmarked to cover premiums for 24 to 36 months beyond the projected LE. If the LE runs long, the reserve absorbs it. If there's no reserve and the insured lives longer than expected, you either put in more capital or the policy lapses — and all your capital goes with it. Ask: Is there a funded premium reserve? How far past the projected LE does it extend?

4. Policy Type and Contestability Period

Most life settlements I've seen work cleanly are universal life (UL) or whole life policies. Term life can qualify, but it introduces expiration risk — if the insured outlives the term, the policy is worth zero. That's a harder deal to price. And then there's the contestability period: for the first two years a policy is in force, the carrier has the legal right to void it if they find material misrepresentation on the original application. Any policy still in that window carries rescission risk, and I generally won't touch it. Ask: Is the policy past the two-year contestability window? What's the policy type? If the answer to either one is weird, walk away. There are always other policies.

5. Full Documentation Access Before Signing

Here's my simple rule: if someone is trying to sell you a life settlement and won't show you the HIPAA-compliant medical records, the actuarial LE report, the carrier rating verification, the in-force ledger, and the policy illustration before you commit capital — leave. I don't care how good the projected return looks. I don't care how urgent they say the deadline is. The institutional investors at the biggest names in this space review every one of those documents before deploying a dollar. You should too. Ask to see everything before you sign anything. If you're told you can review it "after the transaction closes," that's not a transaction I'd do.

• LE report from 21st Services, Fasano Associates, or equivalent top-tier provider — issued or updated within 12 months
• Carrier rated A or above by AM Best — confirmed with a current rating check
• Funded premium reserve extending 24–36 months beyond projected LE
• Policy type confirmed (UL or whole life preferred); contestability period expired
• Full documentation package reviewed before signing: medical records, actuarial report, in-force ledger, policy illustration

If you're looking at a policy and you can't comfortably check all five boxes, my advice is to walk away. There will be other policies. For a deeper look at the specific risks I watch for in this asset class — and how I think about managing them — see High Yield Vault's guide to life settlement investment risks.

Direct ownership vs. life settlement funds: which is right for you

This is probably the question I get asked most often, and my honest answer is: it depends on what you actually want. Both paths work. They're just different tools for different situations. Let me lay out the trade-offs plainly so you can decide which one fits.

Direct ownership makes sense if you want to actually see what you're buying. Every document, every medical record, every LE report. You control which policies you take and which ones you pass on. If the insured passes earlier than expected, that upside goes entirely to you — not to a fund manager's performance fee. The trade-off is concentration: if you own one policy, you own one policy. You manage that by building a portfolio of several policies over time with different LEs and carriers. That's what the institutional allocators do, and it's the model we use for investors in the HYV network.

Life settlement funds make sense if you want to check the box on the asset class without getting into the mechanics of individual policies. You get instant diversification — funds often hold hundreds of policies at once — and you don't have to think about premium servicing or documentation review. The catch is that you're paying management fees plus performance fees, you have no visibility into specific holdings, and when a policy matures early, that upside stays with the fund. For a first-time investor who just wants exposure with minimal involvement, a fund can be a reasonable entry point. I've recommended them when it's the right fit.

What I'd push back on is the idea that funds are automatically "safer" because they're diversified. Diversification is a real advantage, but it's not a substitute for knowing what you own. The Conning 2024 institutional life settlement survey reported that the top reasons institutions prefer direct ownership are transparency, full documentation access, and the absence of layered fees. If those things matter to institutions managing billions, they're probably worth thinking about at any size.

For a deeper side-by-side on these structures and more on what direct ownership actually looks like in practice, see our complete guide to life settlement investments.

How to get started: step by step

Everything I've described above eventually needs to get put into practice, so here's what the process actually looks like if you decide to move forward. I've structured this around one principle I hold myself to with every investor: you see every document before you commit a single dollar. No exceptions, no surprises after signing, no pressure at any stage.

1. 1

   Get in touch

   Start by reviewing the current investor opportunities and requesting a consultation, or call (833) 250-9677. You'll talk to someone who only works on life settlements — not a generalist financial advisor who's going to try to pitch you something else.

2. 2

   Confirm your accreditation and talk through what you're looking for

   Under SEC Rule 501 of Regulation D, an accredited investor is someone with a net worth over $1M excluding primary residence, or annual income above $200,000 ($300,000 jointly). The full legal text is in 17 CFR § 230.501. We'll verify your status and then have an honest conversation about your timeline, capital availability, and what you actually want out of this asset class.

3. 3

   Review the policy documentation — in full

   Before you commit a dollar, you get the full package: HIPAA-compliant medical records, the independent actuarial LE report, carrier rating verification, the in-force ledger with projected premium schedule, and the policy illustration. I walk through it with you and answer every question you have. If something doesn't make sense, we slow down until it does.

4. 4

   Close the deal and take ownership

   Once you're ready, ownership transfers directly to you — or to whatever entity you want to hold it in. You become the owner and sole beneficiary of the policy, backed by the full payment obligation of an A-rated U.S. life insurance carrier. Everything is documented under applicable state-regulated life settlement procedures. Nothing surprising, nothing rushed.

5. 5

   Collect at maturity

   When the policy matures, the insurance carrier pays the full death benefit directly to you as the owner of record. Historical returns on this asset class have averaged 8–12% annually, but I want to be clear: past performance doesn't guarantee future results, and individual returns vary based on how long the insured actually lives. That's the honest framing.

Frequently asked questions

Disclaimer — This content is for educational and informational purposes only and does not constitute financial, legal, tax, or investment advice. Life settlement investments are illiquid, long-duration alternative assets and are not suitable for all investors. Investments involve risk, including potential loss of principal. Life settlements are regulated in 43 U.S. states and are available only to qualified investors as defined by applicable law. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions. High Yield Vault does not guarantee investment returns. High Yield Vault is a life settlement consulting firm; policies are acquired by qualified investors in the HYV network, not by HYV itself.